angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with scopolamine hydrobromide in 3 studies
| Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 311 | 5 | 64 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harding, JW; Pederson, ES; Wright, JW | 1 |
| Harding, JW; Olson, EA; Olson, ML; Qualls, JH; Stratton, JJ; Wright, JW | 1 |
| Cero, IJ; Olson, ML | 1 |
3 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and scopolamine hydrobromide
| Article | Year |
|---|---|
Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog.
Topics: Angiotensin II; Animals; Female; Learning Disabilities; Motor Activity; Rats; Rats, Sprague-Dawley; Scopolamine; Spatial Behavior; Task Performance and Analysis | 1998 |
Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Male; Maze Learning; Mecamylamine; Memory; Memory Disorders; Norleucine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Scopolamine | 2004 |
Intrahippocampal Norleucine¹-Angiotensin IV mitigates scopolamine-induced spatial working memory deficits.
Topics: Angiotensin II; Animals; Hippocampus; Male; Memory Disorders; Norleucine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Scopolamine | 2010 |